OR WAIT null SECS
© 2022 MJH Life Sciences and Optometry Times. All rights reserved.
© 2022 MJH Life Sciences™ and Optometry Times. All rights reserved.
Eyecare professionals examine the emerging role of miotic agents as promising treatment options for the management of patients with presbyopia.
November 23rd 2022
Francis S. Mah, MD, and Andrew S. Morgenstern, OD, FAAO, FNAP, review the impact of presbyopia on quality of life as well as current treatment options and unmet needs for disease management.
Drs Andrew S. Morgenstern and Francis S. Mah provide insight on the functionality of ocular accommodation as an autofocus lens and how this is affected in patients with presbyopia.
December 5th 2022
Expert eye care specialists discuss the role of miotic agents in targeting presbyopia in patients.
Andrew S. Morgenstern, OD, FAAO, FNAP, highlights the importance of reducing pupil size to a certain level to optimize near vision for patients with presbyopia.
Ocuphire submits new drug application for eye drops for reversal of mydriasis
Getting started: methods of initial scleral lens selection
What is presbyopia?
Case report: Combination treatment proves effective for choroidal metastasis from breast cancer patient